Private Trader's Comments RSS Syndication from SeekingAlpha.com http://seekingalpha.comuser/210075/comments http://seekingalpha.com/instablog/210075-private-trader/35639-why-i-m-not-selling-imgg-so-quickly-this-time?source=feed#comment-825439 825439 Tue, 29 Dec 2009 16:46:39 -0500 http://seekingalpha.com/instablog/210075-private-trader/27644-small-article-on-the-small-but-growing-imgg?source=feed#comment-825437 825437 Tue, 29 Dec 2009 16:45:52 -0500 http://seekingalpha.com/instablog/210075-private-trader/35639-why-i-m-not-selling-imgg-so-quickly-this-time?source=feed#comment-765895 765895 Wed, 18 Nov 2009 14:55:46 -0500 http://seekingalpha.com/instablog/210075-private-trader/35639-why-i-m-not-selling-imgg-so-quickly-this-time?source=feed#comment-765878 765878 Wed, 18 Nov 2009 14:46:44 -0500 http://seekingalpha.com/instablog/210075-private-trader/27644-small-article-on-the-small-but-growing-imgg?source=feed#comment-758213 758213 Fri, 13 Nov 2009 02:58:09 -0500 http://seekingalpha.com/instablog/210075-private-trader/27644-small-article-on-the-small-but-growing-imgg?source=feed#comment-715899 715899 Wed, 14 Oct 2009 23:59:01 -0400 http://seekingalpha.com/instablog/210075-private-trader/27644-small-article-on-the-small-but-growing-imgg?source=feed#comment-709881 709881 Fri, 09 Oct 2009 02:46:59 -0400 http://seekingalpha.com/instablog/210075-private-trader/27644-small-article-on-the-small-but-growing-imgg?source=feed#comment-707724 707724 Wed, 07 Oct 2009 18:54:22 -0400 http://seekingalpha.com/article/128017-is-pennantpark-the-best-business-development-company-around?source=feed#comment-691325 691325
www.easyir.com/easyir/...
]]> Fri, 25 Sep 2009 15:22:39 -0400
www.easyir.com/easyir/...
]]> http://seekingalpha.com/instablog/210075-private-trader/27644-small-article-on-the-small-but-growing-imgg?source=feed#comment-691116 691116
My other bases make up for this, and as I said, this company is real, has a warehouse you can visit, a dedicated founder / CEO, and the potential to produce its own invention. While it may travel through some mountains and valleys, I do believe this stock is worth more than $1 in the intermediate term. Don't forget that many of the investors in this stock are doctors or x-ray techs / professionals. They are likely to hold out at least for FDA approval, and perhaps longer - for buy out or production and sales of the Dominion product. Long term, may be worth even more for those who care for an interesting long position. ]]> Fri, 25 Sep 2009 13:05:03 -0400
My other bases make up for this, and as I said, this company is real, has a warehouse you can visit, a dedicated founder / CEO, and the potential to produce its own invention. While it may travel through some mountains and valleys, I do believe this stock is worth more than $1 in the intermediate term. Don't forget that many of the investors in this stock are doctors or x-ray techs / professionals. They are likely to hold out at least for FDA approval, and perhaps longer - for buy out or production and sales of the Dominion product. Long term, may be worth even more for those who care for an interesting long position. ]]> http://seekingalpha.com/article/81477-brazilian-telecom-going-monopolistic?source=feed#comment-688597 688597 Thu, 24 Sep 2009 03:48:19 -0400 http://seekingalpha.com/article/81477-brazilian-telecom-going-monopolistic?source=feed#comment-688596 688596 Thu, 24 Sep 2009 03:47:14 -0400 http://seekingalpha.com/instablog/210075-private-trader/27644-small-article-on-the-small-but-growing-imgg?source=feed#comment-681232 681232 Thu, 17 Sep 2009 15:17:31 -0400 http://seekingalpha.com/article/108879-reconsidering-penny-stocks?source=feed#comment-678523 678523
"What do you mean, gone down?" you might ask. As I recall, for several months that I began to take nibbles, this stock was at trading at approximately .13-.20/share. It was coming down from around .35/share. As I recall, it had hit around .35/share in 2006 after CEO Janes had made a presentation of his product to small cap investors in NYC. He also had gotten a nice write up in a magazine as a stock to watch. As you can imagine, CEO Dean Janes told me that since that event he was upset that the share price had continued to go down -- even though he was doing everything he reasonably could and should be doing to advance his company and product.

Since I had approached him as an investor, he asked me how I could explain why several "hot" companies were trading at $1 or more per share and they did not even have a physical warehouse or headquarters - which I could see that IMGG had. I agreed that it did not make sense that the share price of IMGG was going down from .35/share and not up.

CEO Dean Janes and I did disagree on two things though: in 2006, he sincerely believed that his company would likely be getting FDA approval by the end of 2007. Then he believed investors would flock to his company and GE, Siemens, or some other Buyoutco would probably make him seem crazy not to sell his device. He was thinking that even if IMGG sold the device, IMGG might still have a huge profitable operation going by continuing to develop, upgrade, and repair it.

I told him that I did not believe 2007 would be his year. I thought it would take until at least 2008. I must admit, when 2008 came and the entire stock market seemed upside down, I realized that IMGG might not have the great year that I thought it would in 2008.

However, IMGG is a company that has weathered a severe fire and other set-backs. So when a family member (whom I had advised to buy IMGG in 2006) asked whether he should sell, I said hell NO! I pointed out that to IMGG this storm was business as usual. To GE, this storm was far more life threatening.

Now IMGG's stock has "rushed" up to .24/share. According to yahoo (as of 091509) IMGG has a $63.73M market cap. However, I have seen their warehouse. It is a relatively NEW building. When I visited, it had a LOT of empty space (even though they were using some space for C-arm re-manufacturing).

My argument with CEO Janes was that they should manufacture the Dominion device themselves. At that time he did not like that idea as much because GE could bring a lot of cash to the manufacturing operation that IMGG did not have. - But that was 3 years ago. Now it is not clear to me whether GE, Siemens or any of the potential suitors Janes thought might arrive are in any position to be buying anything.

Furthermore, the Dominion device is not that big. It did not, for example take up much space inside their facility. Plus, for each one of these devices they are able to make and sell, it is my understanding that they would generate approximately $500k in revenue. I do not know how much of that would be profit, but I would imagine that with each device produced, they could make it cheaper and cheaper.

I could be wrong, (I have not had time to keep on on the latest press releases and would look forward to hearing from someone who has) but it seems like the company might now be leaning towards manufacturing Dominions themselves. This is because if they have "luminary sites," then they can force potential buyers to go visit the device, see it in operation, and either special order it, or NOT. This almost eliminates the need for a big marketing team. Instead, IMGG should have someone who simply books orders for the device. Better too many orders than too few orders and lots of extra devices sitting around unsold.

Again, I would argue that although Janes himself may be tired and in need of cash and/or retirement (after all he has dedicated a significant part of his life to the Dominion), but IMGG does not need a buyout as much as it needs buyers. When I say buyers, I do not mean buyers at .35 or even $1/share. I mean buyers of the device. Also, buyers of the software to run it and upgrade it. Also, buyers of the service technicians and parts to fix it.

In the meantime, because this company has a new product which offers better and cheaper images than regular X-ray machines, a driven CEO/founder, no direct competitors, and has the ability to manufacture its own product, software and related components, I think that even .35/share it would be undervalued - especially if the FDA approves its product. So, if you are holding it, I would say be patient. Short term traders may be wise to exit at .35/share. So perhaps there will be a dip for awhile after it hits that. But longer term this could be $1/share stock, and longer term this could be worth far more.


]]> Tue, 15 Sep 2009 22:42:29 -0400
"What do you mean, gone down?" you might ask. As I recall, for several months that I began to take nibbles, this stock was at trading at approximately .13-.20/share. It was coming down from around .35/share. As I recall, it had hit around .35/share in 2006 after CEO Janes had made a presentation of his product to small cap investors in NYC. He also had gotten a nice write up in a magazine as a stock to watch. As you can imagine, CEO Dean Janes told me that since that event he was upset that the share price had continued to go down -- even though he was doing everything he reasonably could and should be doing to advance his company and product.

Since I had approached him as an investor, he asked me how I could explain why several "hot" companies were trading at $1 or more per share and they did not even have a physical warehouse or headquarters - which I could see that IMGG had. I agreed that it did not make sense that the share price of IMGG was going down from .35/share and not up.

CEO Dean Janes and I did disagree on two things though: in 2006, he sincerely believed that his company would likely be getting FDA approval by the end of 2007. Then he believed investors would flock to his company and GE, Siemens, or some other Buyoutco would probably make him seem crazy not to sell his device. He was thinking that even if IMGG sold the device, IMGG might still have a huge profitable operation going by continuing to develop, upgrade, and repair it.

I told him that I did not believe 2007 would be his year. I thought it would take until at least 2008. I must admit, when 2008 came and the entire stock market seemed upside down, I realized that IMGG might not have the great year that I thought it would in 2008.

However, IMGG is a company that has weathered a severe fire and other set-backs. So when a family member (whom I had advised to buy IMGG in 2006) asked whether he should sell, I said hell NO! I pointed out that to IMGG this storm was business as usual. To GE, this storm was far more life threatening.

Now IMGG's stock has "rushed" up to .24/share. According to yahoo (as of 091509) IMGG has a $63.73M market cap. However, I have seen their warehouse. It is a relatively NEW building. When I visited, it had a LOT of empty space (even though they were using some space for C-arm re-manufacturing).

My argument with CEO Janes was that they should manufacture the Dominion device themselves. At that time he did not like that idea as much because GE could bring a lot of cash to the manufacturing operation that IMGG did not have. - But that was 3 years ago. Now it is not clear to me whether GE, Siemens or any of the potential suitors Janes thought might arrive are in any position to be buying anything.

Furthermore, the Dominion device is not that big. It did not, for example take up much space inside their facility. Plus, for each one of these devices they are able to make and sell, it is my understanding that they would generate approximately $500k in revenue. I do not know how much of that would be profit, but I would imagine that with each device produced, they could make it cheaper and cheaper.

I could be wrong, (I have not had time to keep on on the latest press releases and would look forward to hearing from someone who has) but it seems like the company might now be leaning towards manufacturing Dominions themselves. This is because if they have "luminary sites," then they can force potential buyers to go visit the device, see it in operation, and either special order it, or NOT. This almost eliminates the need for a big marketing team. Instead, IMGG should have someone who simply books orders for the device. Better too many orders than too few orders and lots of extra devices sitting around unsold.

Again, I would argue that although Janes himself may be tired and in need of cash and/or retirement (after all he has dedicated a significant part of his life to the Dominion), but IMGG does not need a buyout as much as it needs buyers. When I say buyers, I do not mean buyers at .35 or even $1/share. I mean buyers of the device. Also, buyers of the software to run it and upgrade it. Also, buyers of the service technicians and parts to fix it.

In the meantime, because this company has a new product which offers better and cheaper images than regular X-ray machines, a driven CEO/founder, no direct competitors, and has the ability to manufacture its own product, software and related components, I think that even .35/share it would be undervalued - especially if the FDA approves its product. So, if you are holding it, I would say be patient. Short term traders may be wise to exit at .35/share. So perhaps there will be a dip for awhile after it hits that. But longer term this could be $1/share stock, and longer term this could be worth far more.


]]> http://seekingalpha.com/article/138394-fda-calendar-updates-acusphere-aspenbio-alkermes?source=feed#comment-661346 661346 Fri, 04 Sep 2009 03:09:33 -0400 http://seekingalpha.com/article/81477-brazilian-telecom-going-monopolistic?source=feed#comment-512381 512381 Thu, 21 May 2009 02:34:40 -0400 http://seekingalpha.com/article/132162-yahoo-inc-q1-2009-earnings-call-transcript?source=feed#comment-499754 499754 Mon, 11 May 2009 21:22:43 -0400 http://seekingalpha.com/article/128017-is-pennantpark-the-best-business-development-company-around?source=feed#comment-494592 494592 Thu, 07 May 2009 17:17:32 -0400 http://seekingalpha.com/article/128017-is-pennantpark-the-best-business-development-company-around?source=feed#comment-447069 447069 Tue, 31 Mar 2009 17:11:08 -0400 http://seekingalpha.com/article/127942-canadian-energy-trusts-the-best-long-term-income-and-dollar-hedge?source=feed#comment-441959 441959 Fri, 27 Mar 2009 04:57:08 -0400 http://seekingalpha.com/article/128017-is-pennantpark-the-best-business-development-company-around?source=feed#comment-441936 441936
Specifically, BDC, many of your questions seem to match the conclusions I, too, arrived at after reading Jan's articles. As to your conclusion that the headline was driving things more than fundamentals, please note: my original headline was slightly modified by Seeking Alpha (SA), and I have no objections to that. Last but not least, my article is brief and in it I admit a lack of depth, but I submitted it for posting because on SA I could find nothing else on Pennant. Now, thanks to your and other comments, I can.

NMB, I appreciate your analysis because it helps me stay disciplined in continuing to hold or accumulate ACAS (I started buying it around $28 and it's been hard to keep buying as it goes down; however, as stated, I agree that it seems like it is even more likely to rise when the markets improve - assuming it overcomes creditors / lawsuits (issues PNNT does not have).

Andyyee; prestidigitation (ie - sleight of hand) is my word of the day; I also appreciate the history on BDCs: thanks! The decision of the management of PNNT to adopt FASB 159 (and thus avoid some of the credit / lawsuit issues of ACAS makes a compelling argument that it exercised better judgment than that of ACAS. IMO, your arguments for ARCC make it sound better than PNNT -- IF one can accept the idea that it's okay to payout more of a dividend than NOI (which I think is questionable, and even more so in the current market). Nonetheless, thanks to your arguments, I would consider diversifying my BDC holdings with ARCC, but having missed the ex-dividend date of March 12 (and simultaneous 52 week low), it is now overpriced ($5.14) considering that it's dividend may be cut, changed, or reduced. Congratulations if you bought it earlier, and thanks for putting it on my watchlist. Last but not least, I totally agree that spending is only one part of an economic cycle: employment is a crucial part of it as well. Hopefully, we both agree that America needs either private (not happening) or public (possibly happening) spending to employ people and we don't need that to be dependent on wars in Iraq or Afghanistan, or elsewhere, to "get us out" of our market problems.

Drtrader, I appreciate the recos for hospital reits. I will look into this sector.

Bsharvy, I published this brief article so I could share recent discoveries on BDCs, and PNNT which had no coverage on SA. Fortunately, your critique of my article has lead myself (and perhaps others - though I have not vetted the latter as a fact) to discover more about PNNT on your website. - You're welcome! ]]> Fri, 27 Mar 2009 04:01:38 -0400
Specifically, BDC, many of your questions seem to match the conclusions I, too, arrived at after reading Jan's articles. As to your conclusion that the headline was driving things more than fundamentals, please note: my original headline was slightly modified by Seeking Alpha (SA), and I have no objections to that. Last but not least, my article is brief and in it I admit a lack of depth, but I submitted it for posting because on SA I could find nothing else on Pennant. Now, thanks to your and other comments, I can.

NMB, I appreciate your analysis because it helps me stay disciplined in continuing to hold or accumulate ACAS (I started buying it around $28 and it's been hard to keep buying as it goes down; however, as stated, I agree that it seems like it is even more likely to rise when the markets improve - assuming it overcomes creditors / lawsuits (issues PNNT does not have).

Andyyee; prestidigitation (ie - sleight of hand) is my word of the day; I also appreciate the history on BDCs: thanks! The decision of the management of PNNT to adopt FASB 159 (and thus avoid some of the credit / lawsuit issues of ACAS makes a compelling argument that it exercised better judgment than that of ACAS. IMO, your arguments for ARCC make it sound better than PNNT -- IF one can accept the idea that it's okay to payout more of a dividend than NOI (which I think is questionable, and even more so in the current market). Nonetheless, thanks to your arguments, I would consider diversifying my BDC holdings with ARCC, but having missed the ex-dividend date of March 12 (and simultaneous 52 week low), it is now overpriced ($5.14) considering that it's dividend may be cut, changed, or reduced. Congratulations if you bought it earlier, and thanks for putting it on my watchlist. Last but not least, I totally agree that spending is only one part of an economic cycle: employment is a crucial part of it as well. Hopefully, we both agree that America needs either private (not happening) or public (possibly happening) spending to employ people and we don't need that to be dependent on wars in Iraq or Afghanistan, or elsewhere, to "get us out" of our market problems.

Drtrader, I appreciate the recos for hospital reits. I will look into this sector.

Bsharvy, I published this brief article so I could share recent discoveries on BDCs, and PNNT which had no coverage on SA. Fortunately, your critique of my article has lead myself (and perhaps others - though I have not vetted the latter as a fact) to discover more about PNNT on your website. - You're welcome! ]]> http://seekingalpha.com/article/112914-pengrowth-energy-gold-miners-etf-value-in-commodities?source=feed#comment-440511 440511 Thu, 26 Mar 2009 00:34:10 -0400 http://seekingalpha.com/article/125102-profiting-from-false-breakouts?source=feed#comment-422702 422702 Thu, 12 Mar 2009 03:06:10 -0400 http://seekingalpha.com/article/53398-the-israeli-four-horsemen?source=feed#comment-364757 364757 Sat, 24 Jan 2009 00:38:42 -0500 http://seekingalpha.com/article/100533-fundamental-valuation-how-low-could-we-go?source=feed#comment-285765 285765 Sun, 19 Oct 2008 15:18:33 -0400 http://seekingalpha.com/article/81477-brazilian-telecom-going-monopolistic?source=feed#comment-199519 199519 Mon, 07 Jul 2008 00:49:34 -0400